Welcure Drugs & Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Welcure Drugs & Pharmaceuticals Ltd. from all sources in a single place.

Load latest

Welcure Drugs & Pharmaceuticals Ltd.

30 Sep 2023

7.67

4.92%

AGM

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

The 31st AGM of the Company was held on Thursday, 28th September, 2023 at 12:30 P.M through Video Conferencing mode. We are hereby submitting the copy of Scrutinizer''s Report.

pdf

Welcure Drugs & Pharmaceuticals Ltd.

28 Sep 2023

7.67

4.92%

AGM

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. We hereby submit the proceedings of 31st AGM of the Company. which was held today i.e, Thursday, 28th September, 2023 at 12:30 P.M. through Video Conferencing or other audio video means.

pdf

Welcure Drugs & Pharmaceuticals Ltd.

08 Sep 2023, 02:04PM

7.67

4.92%

Company Update

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are hereby submitting Intimation of Newspaper Advertisement under Regulation 47 of SEBI (LODR) Regulations, 2015 for Notice of 31st AGM of the Company to be held on Thursday, 28th September, 2023 along with the Clippings of Newspapers dated 08th September, 2023.

pdf

Welcure Drugs & Pharmaceuticals Ltd.

06 Sep 2023

7.67

4.92%

Corp. Note

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Reg. 34 (1) Annual Report.

BSE India

We are hereby submitting the Annual Report of Welcure Drugs and Pharmaceuticals Limited for Financial Year ended 2022-23 as required under Regulation 34 of SEBI (LODR) Regulations, 2015.

pdf

Welcure Drugs & Pharmaceuticals Ltd.

06 Sep 2023

7.67

4.92%

AGM

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Intimation Of 31St Annual General Meeting.

BSE India

We wish to inform you that 31st Annual General Meeting of the company will be held on Thursday, 28th September, 2023 through Video Conferencing.

pdf

Welcure Drugs & Pharmaceuticals Ltd.

04 Sep 2023

7.67

4.92%

Corp. Note

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Board Meeting Outcome for Outcome Of The Board …

BSE India

the outcome of the Board Meeting held today i.e. on Monday, 04 Sept, 2023 at 04.30 P.M and concluded at 6.00 P.M at the registered office of the Company.1.The Board considered and approved Financial Statement, Notice of 31st AGM and Director''s Report of the Company 2.The Board appointed Mr. Vivek Kumar as the Scrutinizer for the purpose of 31st Annual General Meeting.3.The Board appointed Mr. Manish Guptaas Internal Auditor of the company for the financial year 2023-24.4. The Board considered the Resignation of M/s V. P. Gupta & Co. from the post of Statutory Auditor etc

pdf

Welcure Drugs & Pharmaceuticals Ltd.

29 Aug 2023

7.67

4.92%

Company Update

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Intimation Pursuant To Regulation 7(4) & 7(5) Of …

BSE India

In Terms of Regulation 7(4) & 7(5) of SEBI(LODR) Regulations, 2015. We would like to inform that the Company has entered into Tripartite Agreement on 22nd August, 2023 with Skyline Financial Services Private Limited (New RTA) and Link Intime India Private Limited (Old RTA).

pdf

Welcure Drugs & Pharmaceuticals Ltd.

16 Aug 2023

7.67

4.92%

Company Update

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

In continuation to our letter dated 14th August,2023, regarding approval of Un-Audited Financial Results for Quarter ended 30th June, 2023; Please find enclosed, the newspaper advertisement published, in compliance with Regulation 47 of SEBI(LODR) Regulations, 2015 in The Pioneer (English) and Pioneer(Hindi) on 15th August, 2023.

pdf

Welcure Drugs & Pharmaceuticals Ltd.

14 Aug 2023

7.67

4.92%

Company Update

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Submission Of Disclosure Under Regulation 32 Of SEBI …

BSE India

Regulation 32 of SEBI (LODR) regulations, 2015 is not applicable on our company for the Quarter ended June 30, 2023.

pdf

Welcure Drugs & Pharmaceuticals Ltd.

14 Aug 2023

7.67

4.92%

Result

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Submission Of Un-Audited Financial Results Of The Company …

BSE India

In terms of Regulation 33 read with Regulation 30 of SEBI(LODR) Regulation, 2015, un-audited financial results for the quarter ended June 30, 2023 along with Limited Review Report.

pdf

Is Welcure Drugs & Pharmaceuticals Ltd. worth buying?

60 Votes:

Buy 78.33%

Sell 8.33%

Hold 13.33%